Drug development

#Biotechnology #Drug development #Drug discovery #Life sciences #Narrated podcasts #Pharmaceutical #Research

Evolution of User Experience for life sciences

Since 2017 we have seen the slow and steady adoption of User Experience (UX) within the life sciences. User Experience is an evidence-based design process that centres on the behaviours and needs of users. The clear benefits of UX offered in the retail and consumer sectors have been slow to… Read More

#Podcasts

#AI / data analytics / healthtech / informatics #Drug development #Drug discovery #Oncology #Therapeutics

Lantern Pharma AI milestone will cut cost, time and risk in developing new drug therapies

Lantern Pharma has reached a significant milestone by surpassing one billion curated data points on its RADR platform, a total it believes is the most amassed by any company in the biotech sector. The milestone, which was reached well ahead of schedule, enables new opportunities in Lantern’s work to identify and… Read More

#News

#AI / data analytics / healthtech / informatics #Clinical trials #Drug development #Therapeutics

First patient recruited for novel precision medicine trial for patients with hypertension

Closed Loop Medicine (CLM) a clinical stage therapeutics company developing drug and digital combination products, has recruited the first patient into its pivotal clinical trial investigating CLM’s integrated precision care solution for patients with hypertension. The clinical trial, called Personal COVID BP, will see up to 1,000 patients recruited for… Read More

#News

#AI / data analytics / healthtech / informatics #Covid-19 #Drug development

Is virtual reality the new tool for COVID-19 drug design?

Bristol scientists have demonstrated a new virtual reality [VR] technique which should help in developing drugs against the SARS-CoV-2 virus – and enable researchers to share models and collaborate in new ways. The innovative tool, created by University of Bristol researchers, and published in the Journal of Chemical Information and… Read More

#Covid-19 #Editor's Choice #News

#Biotechnology #Drug development #Drug discovery #Ingredients / APIs / Fine chemicals #Pharmacokinetics / Pharmacodynamics

Evotec expands UK site into drug discovery & development centre

Evotec is expanding its campus in Abingdon, Oxfordshire, UK, into a major, fully-integrated, co-located discovery and development centre to be named Dorothy Crowfoot Hodgkin Campus. Adding a new building, which will house up to 100 biologists by the end of the year, will bring together all the key functions for… Read More

#News

#Biotechnology #Drug development #Drug discovery #Narrated podcasts #Pharmaceutical

Evolving Models for NASH Drug Discovery: Tools for stemming a silent epidemic

Non-alcoholic fatty liver disease (NAFLD) has quietly become one of the most common causes of chronic liver disease in the modern world. If this prevalence is allowed to continue the economic and clinical burden will reach a staggering level. Non-alcoholic fatty liver disease (NAFLD) consists of a complex combination of… Read More

#Podcasts

#Drug development #Gene therapy

Oxford Biomedica and PhoreMost enter gene therapy discovery collaboration

Oxford Biomedica, gene and cell therapy group and PhoreMost, the UK-based biopharmaceutical company dedicated to developing drugs against intractable disease targets, have entered into a discovery collaboration to develop next-generation CAR-T cell therapies. Financial details of the agreement are not disclosed. PhoreMost will deploy its in-house expertise and next-generation phenotypic… Read More

#Editor's Choice #News

#Drug development

Vary drug prices for different conditions, say health experts

According to a group of experts from across academia and industry, the NHS could improve patients’ access to new cancer treatments by paying different prices for drugs depending on the disease they are used to treat. The consensus panel, representing 16 leading academic institutions, charities, stakeholder groups and pharmaceutical companies,… Read More

#Editor's Choice #News

#Biopharma #Drug development #Drug discovery

Thermo Fisher Scientific extends collaboration to advance biopharma discovery

Thermo Fisher Scientific and Symphogen, an affiliate of and the antibody centre of excellence within the international pharmaceutical company, Servier, have extended a collaboration to deliver innovative characterisation and quality control workflows for the simplified analysis of complex therapeutic proteins to advance biopharmaceutical discovery and development. Since the collaboration was… Read More

#News

#Drug development #Drug discovery #Oncology

New drug for difficult-to-drug cancer mutation could be key treatment for other cancers

A new drug designed to counter the effects of an important, but very hard to target, cancer mutation could be effective against a range of tumour types including lung and gynaecological cancers, a new clinical trial shows. Researchers used an innovative, intermittent treatment schedule to limit the drug’s toxicity, and… Read More

#Cancer Research #News #Trending News

#Drug development #Pharmacokinetics / Pharmacodynamics

TherapeutAix teams up with CROs to solve PK/PD challenges

Life sciences consultancy, TherapeutAix, has added contract research organisations (CROs), Alderley Analytical and Peak Proteins to its global R&D network, forming a dedicated and expert team to solve Pharmacokinetics and Pharmacodynamics (PK/PD) challenges faced by clients. Based in Aachen, Germany, TherapeutAix is a biotech consultancy providing services from strategic planning… Read More

#News

#ADME / Tox #Drug development

CN Bio to provide drug metabolism and safety toxicity testing services 

The 3D cell culture company, CN Bio, has launched Drug Metabolism and Safety Toxicity Testing Services. Liver toxicity is a principal safety concern during drug discovery and development, with the potential to terminate expensive clinical trials already underway. The new services will incorporate the company’s advanced Liver-on-Chip technology and expertise… Read More

#News

#Biotechnology #Drug development #Drug discovery #Life sciences #Narrated podcasts #Pharmaceutical

Reducing the PAINS in High Throughput Screening: Assay design as a tool for maximising efficiency

This article will describe, with examples, how understanding the likely mechanisms of false positives in advance of screening informs the design of the hit triage, thus increasing the likelihood of discovering optimisable chemical matter and avoiding costly wasting of resource. We describe the use of a bespoke ‘Robustness Set’ of… Read More

#Podcasts

#Covid-19 #Drug development #Therapeutics

Aerogen collaborates on development of COVID-19 inhaled therapies

Aerogen has released details of a collaborative effort to support global pharmaceutical companies developing COVID-19 vaccines and therapies. To date, more than ten million patients globally have been treated safely and effectively with Aerogen’s drug delivery technology. As the global scientific community rallies against the pandemic, there has been interest… Read More

#Covid-19 #News